CXCR4-gerichtete Endoradiotherapie von hämatologischen Erkrankungen
C Lapa, H Hänscheid, KM Kortüm… - Der …, 2019 - thieme-connect.com
Der CXC Chemokinrezeptor 4 (CXCR4) spielt sowohl in der Physiologie als auch
Pathologie des Menschen eine wichtige Rolle, so z. B. in der Embryo-und Organogenese …
Pathologie des Menschen eine wichtige Rolle, so z. B. in der Embryo-und Organogenese …
Post-Infarction Inflammatory Alterations
K van der Heiden, BJ Krenning, D Merkus… - Imaging of Inflammation …, 2021 - Springer
Acute myocardial infarction is one of the leading causes of death in the western world.
Timely implementation of reperfusion therapy has resulted in increased survival and is …
Timely implementation of reperfusion therapy has resulted in increased survival and is …
Longitudinal evolution of 68 Ga-Pentixafor uptake in the remote myocardium early after acute myocardial infarction and its association with left ventricular remodelling
P Wu, L Xu, Q Wang, X Ma, X Wang, H Wang, S He… - 2022 - researchsquare.com
Purpose Previous studies have initially reported accompanying elevated 18 F-FDG
inflammatory signal in the remote area and its prognostic value after acute myocardial …
inflammatory signal in the remote area and its prognostic value after acute myocardial …
Molecular Imaging of Vulnerable Plaque
R Laudicella, K Christel, IA Burger, S Baldari… - Imaging of Inflammation …, 2021 - Springer
Many cellular and molecular pathways are involved in the pathogenesis of vulnerable
plaque. The developing role of new nuclear medicine imaging techniques surpassed the …
plaque. The developing role of new nuclear medicine imaging techniques surpassed the …
Análisis de subpoblaciones monocitarias y su asociación con el riesgo cardiovascular. Hallazgo de nuevos biomarcadores séricos: SDF1 y MMP-12
M Marcos-Jubilar - 2021 - dadun.unav.edu
En la actualidad, la prevalencia de las enfermedades cardiovasculares (ECV) es de 108, 7
millones de personas, presentando una incidencia anual de 19, 9 millones de casos nuevos …
millones de personas, presentando una incidencia anual de 19, 9 millones de casos nuevos …
Design and development of a new vector platform for CXCR4-targeted molecular imaging and radionuclide therapy
K Luyten - 2022 - lirias.kuleuven.be
The CXC chemokine receptor 4 (CXCR4) is a well-described G protein-coupled receptor
(GCPR) that is involved in different physio-pathological processes upon binding of its …
(GCPR) that is involved in different physio-pathological processes upon binding of its …
[PDF][PDF] DEVELOPMENT OF RADIOPHARMACEUTICALS FOR PET IMAGING OF INFLAMMATION
O Moisio - utupub.fi
Positron emission tomography (PET) is a non-invasive technology widely used in oncology,
cardiology, neurology and inflammation imaging. PET can detect the expression of …
cardiology, neurology and inflammation imaging. PET can detect the expression of …
Der Chemokinrezeptor CXCR4–seine Entwicklung und Bedeutung in der nuklearmedizinischen Theranostik
C Bergner, A Gummesson, M Joksch… - Der …, 2021 - thieme-connect.com
Der Chemokinrezeptor CXCR4–häufig nachgewiesen, doch selten greifbar. Während in
einer schier endlosen Zahl an Studien seine physiologische und pathogene Präsenz, seine …
einer schier endlosen Zahl an Studien seine physiologische und pathogene Präsenz, seine …
Cyclic pentapeptide-based CXCR4 ligands for various applications within cancerous malignancies
ML Konrad - 2021 - mediatum.ub.tum.de
In this work, new CXCR4-targeted ligands were prepared, based on a highly affine cyclic
pentapeptide. The ligands can be radiolabeled with Tc-99m, F-18, Ga-68, Lu-177, etc. and …
pentapeptide. The ligands can be radiolabeled with Tc-99m, F-18, Ga-68, Lu-177, etc. and …